Skip to content
Subscriber Only

U.S. Warns Shkreli May Face More Charges in Securities Case

  • Prosecutor says he may file new indictment against ex-CEO
  • 'Hated' biotech founder asks to put off setting a trial date
Video player cover image

Watch Martin Shkreli Take the Fifth and Laugh at Congress

Updated on

Disgraced drug company founder Martin Shkreli isn’t rushing to have his next showdown with the government. The 33-year-old former executive asked a judge to wait before setting a trial date for his securities fraud case because he could soon face more charges.

The founder of Turing Pharmaceuticals AG, called the "most hated man in America" by some in the media for dramatically increasing the price of a life-saving drug, is charged with defrauding investors in hedge funds and Retrophin Inc., another pharmaceutical company he ran.